medigraphic.com
SPANISH

Revista Cubana de Cardiología y Cirugía Cardiovascular

ISSN 1561-2937 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2022; 28 (1)

Obstetric complications as a risk factor for coronary artery disease

Borges MY, Peix GA, Castelo VX, Heres ÁF, Martínez CA, Guevara MG
Full text How to cite this article

Language: Spanish
References: 19
Page: 1-6
PDF size: 222.64 Kb.


Key words:

gestational complications, coronary artery disease, coronary risk factors.

ABSTRACT

Gestational complications such as preeclampsia, gestational diabetes mellitus and prematurity influence on cardiovascular risk and long-term adverse outcomes.
Objective: To identify obstetric complications as a risk factor for coronary artery disease.
Methods: A search was carried out in sources, both in Spanish and English, and databases such as Pubmed, Dialnet, SciELO, Scopus, national and international journals of high scientific impact such as those from the American Heart Association, American College of Cardiology, Journals of the American College of Cardiology and European Society of Cardiology, etc. Keywords were defined to search for obstetric complications as a risk factor for coronary artery disease. Articles published before 2011-2021 period were excluded. Fifty articles were consulted and 19 were selected for the review.
Results: The aforementioned documents refer to the fact that gestational diabetes mellitus implies twice the risk of heart disease, which is why it is considered an emerging cardiovascular risk factor; preeclampsia is associated with a twofold increased risk of coronary artery disease, stroke, death, and a fourfold increased risk of future heart failure; preterm delivery is associated with an increase in future adverse maternal cardiovascular outcomes.
Conclusions: Gestational diabetes mellitus, preeclampsia and preterm birth increase the risk of coronary artery disease.


REFERENCES

  1. Piepoli MF, Hoes AW, Agewall S, Albus CH, Brotons C, Catapano AL et al. Comentarios a la guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Esp Cardiol. [Internet] 2016 Feb [citado 20 Oct 2020];69(10):894-9. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893216304146.

  2. Haywood B, John JW, Gianos E, Gulati M, Hill AJ, Hollier ML et al. Promoting risk identification and redution disease in women through collaboration gynecologists: A presidential advisory from association and the American college of Gynecologists. Circulation [Internet]. 2018 Jun [cited 2020 Oct 4] ;137: 843-52. Available from: htttps://doi.org/10.1161/CIR.000000000000582

  3. Bassily E, Bell C, Verma S, Patel N, Patel A. Significance of obstetrical History with Future Cardiovascular Disease Risk. The American Journal of Medicine 2018. DOI: https://doi.org/10.1016/j.amjmed.2018.11.029.

  4. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd- Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: A guideline from the American Heart Association. J Am Coll Cardiol. 2011; 57:1404–23. Disponible en: https://doi.org/10.1161/CIR.0b013e31820faaf8

  5. Novack K, Vrdoljak D, Jelaska I, Borovac JA. Sex-specific differences in risk factors for in-hospital mortality and complications in patients with acute coronary syndromes. Wien Klin Wochenschr [Internet]. 2017Apr [cited 2019Apr17];129(7-8):232-42. Available from: https://link.springer.com/content/pdf/10.1007%2Fs00508-016-1105-7.pdf

  6. Merz CNB, RamineniT, Leong D. Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real. CurrOpinCardiol 2018; 33:500–505. Disponible en: https://doi.org/ 10.1097/HCO. 0000000000000543.

  7. García M. Factores de riesgo cardiovascular desde la perspectiva de sexo y género. Rev Colomb Cardiol. 2018;25(S1):8-12. Disponible en: https://doi.org/10.1016/j.rccar.2017.11.021.

  8. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. cardiovascular disease related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019; 139:1069–1079. Disponible en: https://doi.org/10.1161/ CIRCULATIONAHA.118.036748.

  9. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and Future Cardiovascular Health A Systematic Review and Meta-Analysis. CircCardiovascQualOutcomes. 2017; 10: e003497.Dispoible en: https://doi.org/ 10.1161/CIRCOUTCOMES.116.003497.

  10. Valdés G. Preeclampsia y enfermedad cardiovascular: un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y cardiovasculares. Rev ChilCardiol 2019; 38: 132-145. Disponible en: http://dx.doi.org/10.4067/S0718-85602019000200132.

  11. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden CH, Budaj A, et al. Guía de prácticas clínicas de la ESC sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Rev Esp Cardiol [Internet]. 2014 Ene [citado 20 Oct 2020];67(2):80-86. Disponible en: https://www.revespcardiol.org/es-pdf-S030089321400030X.

  12. McDonald SD, Ray J, Teo K, Jung H, Salehian O, Yusuf S et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 2013;229(1):234-239. Disponible en: https://doi.org/ 10.1016/j.atherosclerosis.2013.04.020

  13. Wu P, Mamas AM. Gulati M. Pregnancy as a predictor of maternal cardiovascular disease: The era of CardioObstetrics. Journal of Women's Health. 2019; 28.8: 1037-1050. Disponible en: https://doi.org/10.1089/jwh.2018.7480

  14. Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Web-ber J, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study. PLoSMed. 2018;15(1): e1002488, http://dx.doi.org/10.1371/journal.pmed.1002488.4

  15. Basily Smith GD, Whitley E, Gissler M, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of mothers. The Lancet. 2000; 356 (9247) :2066-2067. https://doi.org/10.1016/j.amjmed.2018.11.029

  16. Kramer C K, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019; 62(6): 905-914. Disponible en: https://doi.org/10.1007/s00125-019-4840-2

  17. Duran A. Diabetes gestacional: ¿Es tiempo de cambiar el riesgo cardiovascular en las mujeres? Endocrinología, Diabetes y Nutrición. 2019; 66(4): 207-209. Disponible en: https://doi.org/10.1016/j.endinu.2019.03.002

  18. Risse HK, Sulo G, Tell GS, Igland J, Nygard O, Vollset SE, et al. Incident coronary heart disease after preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. J Am Heart Assoc 2017;6: e004158. Disponible en: https://doi.org/10.1161/JAHA.116.004158

  19. Saldarriaga CI, Franco G, Garzón AM, García I, Mejía N, Restrepo A. Factores de riesgo para la enfermedad coronaria temprana en mujeres. Biomédica [Internet] 2010 May [citado 23 Abr 2019]; 30:559-66. Disponible en: http://www.scielo.org.co/pdf/bio/v30n4/v30n4a13.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Cardiol Cir Cardiovasc. 2022;28